EG24072A - Process for preparing 10,11-methanobenzosube rane derivatives - Google Patents

Process for preparing 10,11-methanobenzosube rane derivatives

Info

Publication number
EG24072A
EG24072A EG20000680A EG20000680A EG24072A EG 24072 A EG24072 A EG 24072A EG 20000680 A EG20000680 A EG 20000680A EG 20000680 A EG20000680 A EG 20000680A EG 24072 A EG24072 A EG 24072A
Authority
EG
Egypt
Prior art keywords
methanobenzosube
rane
derivatives
preparing
rane derivatives
Prior art date
Application number
EG20000680A
Other languages
English (en)
Inventor
Bret E Huff
Original Assignee
Elililly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elililly And Company filed Critical Elililly And Company
Application granted granted Critical
Publication of EG24072A publication Critical patent/EG24072A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
EG20000680A 1999-06-03 2000-05-27 Process for preparing 10,11-methanobenzosube rane derivatives EG24072A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13728399P 1999-06-03 1999-06-03

Publications (1)

Publication Number Publication Date
EG24072A true EG24072A (en) 2008-05-11

Family

ID=22476642

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20000680A EG24072A (en) 1999-06-03 2000-05-27 Process for preparing 10,11-methanobenzosube rane derivatives

Country Status (18)

Country Link
US (1) US6521755B1 (pt)
EP (1) EP1189887A2 (pt)
JP (1) JP2003501421A (pt)
KR (1) KR100692351B1 (pt)
AR (1) AR037068A1 (pt)
AU (1) AU5123300A (pt)
BR (1) BR0011559A (pt)
CA (1) CA2378735A1 (pt)
CO (1) CO5170530A1 (pt)
EG (1) EG24072A (pt)
HU (1) HUP0203421A3 (pt)
IL (2) IL146810A0 (pt)
MX (1) MXPA01012296A (pt)
MY (1) MY123517A (pt)
PE (1) PE20010216A1 (pt)
SV (1) SV2002000088A (pt)
TW (1) TWI267511B (pt)
WO (1) WO2000075121A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60014386T2 (de) * 1999-06-03 2005-10-13 Eli Lilly And Co., Indianapolis Verfahren zur herstellung von 10,11methanodibenzosuberanderivaten
WO2002005818A2 (en) * 2000-07-18 2002-01-24 Eli Lilly And Company Novel method of use of multidrug resistance modulators
DE60202944T2 (de) 2001-04-25 2006-03-23 Eli Lilly And Co., Indianapolis Neue salze und kristalline formen von (2r)-anti-5-3-(4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypropoxy quinolin
US11930815B1 (en) 2023-08-29 2024-03-19 King Faisal University 3,3′-(piperazine-1,4-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as insecticidal agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
JPS6147466A (ja) * 1984-08-10 1986-03-07 Dainippon Pharmaceut Co Ltd アミン誘導体
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US5643909A (en) 1993-04-19 1997-07-01 Syntex (U.S.A.) Inc. 10,11-Methanodibenzosuberane derivatives

Also Published As

Publication number Publication date
PE20010216A1 (es) 2001-02-27
JP2003501421A (ja) 2003-01-14
CO5170530A1 (es) 2002-06-27
CA2378735A1 (en) 2000-12-14
US6521755B1 (en) 2003-02-18
IL146810A0 (en) 2002-07-25
KR100692351B1 (ko) 2007-03-09
HUP0203421A2 (hu) 2003-02-28
MXPA01012296A (es) 2002-07-30
AR037068A1 (es) 2004-10-20
SV2002000088A (es) 2002-01-23
HUP0203421A3 (en) 2003-05-28
TWI267511B (en) 2006-12-01
BR0011559A (pt) 2002-02-26
WO2000075121A2 (en) 2000-12-14
IL146810A (en) 2007-06-03
WO2000075121A3 (en) 2001-04-26
MY123517A (en) 2006-05-31
KR20020038587A (ko) 2002-05-23
EP1189887A2 (en) 2002-03-27
AU5123300A (en) 2000-12-28

Similar Documents

Publication Publication Date Title
ZA200203252B (en) Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
HUP0203206A3 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
HUP0103659A3 (en) Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
IL144697A0 (en) Microbial process for preparing paravastatin
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
ZA200108623B (en) Process for preparing imidachloprid.
HUP0200144A3 (en) Process for preparing pesticidal 5-amino-1-aryl-3 cyanopyrazole derivatives, and the new intermediates
IL142285A0 (en) Process for preparing phenoxazine derivatives
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
HUP0000907A3 (en) Process for preparing 3-oxo-pyrazolo-[4,3-c]pyridine derivatives
IL141048A0 (en) Process for preparing 3,5-difluoroaniline
EG24072A (en) Process for preparing 10,11-methanobenzosube rane derivatives
IL145791A0 (en) Process for preparing mkc-442
IL146573A0 (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
IL142341A0 (en) Process for preparing 1,5-diaryl-3-substituted pyrazoles
HUP0201559A3 (en) Process for preparing benzimidazole derivatives and their intermediates, and the novel intermediates
HUP0000559A3 (en) Process for preparing cyanoaceticacidesters
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
ZA200104182B (en) Process for preparing trichloroalkane derivatives.
GB9914600D0 (en) Novel,process
ZA200005740B (en) Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives.
HUP0202890A3 (en) Method for preparing quinoline-5,8-diones
HUP0101063A3 (en) Process for preparing alkoxytriazolinone derivatives
HUP0000208A3 (en) Process for producing secondary-alkoxy-1-alkene derivatives
HU9901547D0 (en) Process for producing n,n-dimethyl-cyclohexyl-amine